NOI to Sole Source to One Lambda, Inc.
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) intends to award a fixed-price purchase order on a sole source basis to One Lambda, Inc. for specific HLA typing and antibody screening reagents. This Notice of Intent (NOI) is for critical reagents used by the NIH HLA Lab for clinical diagnostic testing and patient care. Interested parties must submit capabilities by March 30, 2026.
Purpose & Rationale for Sole Source
NIH's HLA Lab currently uses these reagents, which have been extensively tested and validated, providing superior ability to resolve testing ambiguities. One Lambda, Inc. is the sole provider of the required LABType, LABScreen, and Secore kits. A change in vendors would necessitate approximately two months of extensive validation, significantly impacting the lab's ability to provide timely results and patient care. This acquisition is being conducted under FAR Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1).
Scope of Requirement
The reagents are essential for the Human Leukocyte Antigen Laboratory (HLA) of the Department of Transfusion Medicine, CC. The lab's functions include:
- Clinical diagnostic testing for transplant patients.
- Clinical consultations for patient care management.
- Maintaining accreditation.
- Research in diagnostic test development.
- Supporting protocols involving HLA testing.
Contract Details
- Type: Fixed-Price Purchase Order (Sole Source)
- Product Service Code: J066 - Maintenance, Repair And Rebuilding Of Equipment: Instruments And Laboratory Equipment
- NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing
- Set-Aside: None (Sole Source)
- Place of Performance: Bethesda, MD 20892, United States
- Proposed Vendor: One Lambda, Inc., 22801 Roscoe Blvd, West Hills, CA 91304
Submission Instructions for Interested Parties
This is a Notice of Intent, not a request for quotation, and a solicitation document will not be issued. Any firm believing they can provide the required reagents and wish to identify their capabilities must submit their interest via email to the contracting officer. The government reserves the sole discretion to determine whether to compete this requirement based on responses.
- Response Due: March 30, 2026, at 12:00 PM EST
- Contact: Huda Malik (huda.malik@nih.gov)
- Published Date: March 23, 2026